🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well radiation therapy works in treating po...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2013-05
Trial ID
NCT01754519
This phase II trial studies how well chemotherapy before surgery and radiat...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2019-03-12
Trial ID
NCT03493425
Robot-assisted training (RT) devices developed to date have a significant i...
Status
Completed
Location
Chang Gung Memorial Hospital
Start Date
2013-01
Trial ID
NCT01767480
Treatments Being Tested
Voltage-gated sodium channels, especially Nav1.7 encoded by the SCN9A gene,...
Status
Recruiting
Location
Faculty of Dentistry
Start Date
2026-04-10
Trial ID
NCT07532200
Treatments Being Tested
This randomized phase II/III trial studies how well pazopanib, when combine...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2014-08-12
Trial ID
NCT02180867
In this study the patient will receive either whole brain radiation therapy...
Status
Unknown
Location
Good Samaritan Hospital Medical Center
Start Date
2013-06
Trial ID
NCT01890278
Treatments Being Tested
Brain tumours are the commonest solid tumours in children and the second mo...
Status
Unknown
Location
Tata Memorial Centre
Start Date
2001-05
Trial ID
NCT00517959
Treatments Being Tested
This phase III trial compares stereotactic body radiation therapy (SBRT), (...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-12-14
Trial ID
NCT05946213
This phase II trial studies how well nab-paclitaxel and gemcitabine hydroch...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-21
Trial ID
NCT02427841
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested